Key result
Systematic review evaluates statin therapy for managing dyslipidemia and reducing CV risk in hypertension.
Why the study?
This dissertation examined the roles of statins in managing dyslipidemia and reducing cardiovascular disease risks among patients with hypertension.
Do statins improve lipid profiles, blood pressure, and cardiovascular outcomes in patients with hypertension?
Systematic Review
Do statins improve lipid profiles, blood pressure, and cardiovascular outcomes in patients with hypertension?
This master's dissertation systematically reviewed eight studies to examine the effects of statin therapy on lipid profiles, blood pressure, cardiovascular outcomes, and adverse events in patients with hypertension.
Answers are grounded in this paper and cite their sources.
Statin integration in hypertensive dyslipidaemia remains hypothesis-generating; leaves open optimal selection, BP effects, and long-term outcomes.
This master's dissertation examines the roles of statins in managing dyslipidaemia and reducing cardiovascular disease risks in patients with hypertension. The study adopted a systematic literature review approach to examine evidence concerning the effects of statins on lipid profiles, blood pressure, cardiovascular outcomes, and adverse events among patients with hypertension. The literature search covered electronic databases and sources including Google Scholar, Cochrane, ProQuest, PubMed, PubMed Central, and ScienceDirect. The review screened 175 studies and included eight studies for analysis. The dissertation discusses the potential contributions of statin therapy to lipid management and cardiovascular risk reduction in people with hypertension, alongside considerations relating to adverse effects. Author: Daniel AdeyemiQualification: Master of Public Health (MPH)Institution: University of Wolverhampton, United KingdomOriginal dissertation submission date: 9 September 2024 This work was submitted as a research dissertation in fulfilment of the academic requirements of the Master of Public Health programme.
No takes yet. Share an insight, caveat, or question.
Daniel Oluwaseyi Adeyemi (2026) conducted a systematic review in Hypertension and dyslipidemia. Statins was evaluated on Lipid profiles, blood pressure, cardiovascular outcomes, and adverse events. Statin therapy was evaluated across 8 included studies (of 175 screened) for managing dyslipidemia and reducing cardiovascular risk in patients with hypertension, with no numerical results reported.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: